| Anush Mahendra Parikh, MD | |
|
710 S Queen St, Dover, DE 19904 | |
| (302) 734-9888 | |
| (302) 734-2780 |
| Full Name | Anush Mahendra Parikh |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 21 Years |
| Location | 710 S Queen St, Dover, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780829341 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | C1-0008740 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Delaware Radiology Associates Pa | 1557620036 | 36 |
| First State Orthopaedics Pa | 6103800057 | 69 |
News Archive
Hearing loss is a marginalizing and disabling condition, resulting in various adverse social and health outcomes. Babies born to women with hearing loss were significantly more likely to be premature and have low birth weight, according to a new study in the American Journal of Preventive Medicine.
In what the authors believe is the first documented comparison of several real-time infectious disease forecasting models by different teams across many seasons, five research groups report this week that a majority of models consistently showed higher accuracy than historical baseline models.
Allos Therapeutics, Inc. announced today that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of cutaneous T-cell lymphoma (CTCL). The Company is currently investigating pralatrexate in a Phase 1 clinical study in patients with relapsed or refractory CTCL.
Medco Health Solutions, Inc. today reported record fourth-quarter 2011 GAAP diluted EPS of $1.08, an increase of 22.7 percent, which includes expenses associated with the pending merger with Express Scripts, Inc. of $43.6 million before provision for income taxes. When excluding these merger-related expenses, diluted EPS increased 29.5 percent over fourth-quarter 2010.
› Verified 1 days ago
| Entity Name | First State Orthopaedics Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346220266 PECOS PAC ID: 6103800057 Enrollment ID: O20040617000139 |
News Archive
Hearing loss is a marginalizing and disabling condition, resulting in various adverse social and health outcomes. Babies born to women with hearing loss were significantly more likely to be premature and have low birth weight, according to a new study in the American Journal of Preventive Medicine.
In what the authors believe is the first documented comparison of several real-time infectious disease forecasting models by different teams across many seasons, five research groups report this week that a majority of models consistently showed higher accuracy than historical baseline models.
Allos Therapeutics, Inc. announced today that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of cutaneous T-cell lymphoma (CTCL). The Company is currently investigating pralatrexate in a Phase 1 clinical study in patients with relapsed or refractory CTCL.
Medco Health Solutions, Inc. today reported record fourth-quarter 2011 GAAP diluted EPS of $1.08, an increase of 22.7 percent, which includes expenses associated with the pending merger with Express Scripts, Inc. of $43.6 million before provision for income taxes. When excluding these merger-related expenses, diluted EPS increased 29.5 percent over fourth-quarter 2010.
› Verified 1 days ago
| Entity Name | Mid-delaware Imaging,pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841369600 PECOS PAC ID: 9931108297 Enrollment ID: O20061214000107 |
News Archive
Hearing loss is a marginalizing and disabling condition, resulting in various adverse social and health outcomes. Babies born to women with hearing loss were significantly more likely to be premature and have low birth weight, according to a new study in the American Journal of Preventive Medicine.
In what the authors believe is the first documented comparison of several real-time infectious disease forecasting models by different teams across many seasons, five research groups report this week that a majority of models consistently showed higher accuracy than historical baseline models.
Allos Therapeutics, Inc. announced today that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of cutaneous T-cell lymphoma (CTCL). The Company is currently investigating pralatrexate in a Phase 1 clinical study in patients with relapsed or refractory CTCL.
Medco Health Solutions, Inc. today reported record fourth-quarter 2011 GAAP diluted EPS of $1.08, an increase of 22.7 percent, which includes expenses associated with the pending merger with Express Scripts, Inc. of $43.6 million before provision for income taxes. When excluding these merger-related expenses, diluted EPS increased 29.5 percent over fourth-quarter 2010.
› Verified 1 days ago
| Entity Name | Delaware Radiology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740706175 PECOS PAC ID: 1557620036 Enrollment ID: O20180108001828 |
News Archive
Hearing loss is a marginalizing and disabling condition, resulting in various adverse social and health outcomes. Babies born to women with hearing loss were significantly more likely to be premature and have low birth weight, according to a new study in the American Journal of Preventive Medicine.
In what the authors believe is the first documented comparison of several real-time infectious disease forecasting models by different teams across many seasons, five research groups report this week that a majority of models consistently showed higher accuracy than historical baseline models.
Allos Therapeutics, Inc. announced today that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of cutaneous T-cell lymphoma (CTCL). The Company is currently investigating pralatrexate in a Phase 1 clinical study in patients with relapsed or refractory CTCL.
Medco Health Solutions, Inc. today reported record fourth-quarter 2011 GAAP diluted EPS of $1.08, an increase of 22.7 percent, which includes expenses associated with the pending merger with Express Scripts, Inc. of $43.6 million before provision for income taxes. When excluding these merger-related expenses, diluted EPS increased 29.5 percent over fourth-quarter 2010.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anush Mahendra Parikh, MD 710 S Queen St, Dover, DE 19904-3567 Ph: (302) 734-9888 | Anush Mahendra Parikh, MD 710 S Queen St, Dover, DE 19904 Ph: (302) 734-9888 |
News Archive
Hearing loss is a marginalizing and disabling condition, resulting in various adverse social and health outcomes. Babies born to women with hearing loss were significantly more likely to be premature and have low birth weight, according to a new study in the American Journal of Preventive Medicine.
In what the authors believe is the first documented comparison of several real-time infectious disease forecasting models by different teams across many seasons, five research groups report this week that a majority of models consistently showed higher accuracy than historical baseline models.
Allos Therapeutics, Inc. announced today that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of cutaneous T-cell lymphoma (CTCL). The Company is currently investigating pralatrexate in a Phase 1 clinical study in patients with relapsed or refractory CTCL.
Medco Health Solutions, Inc. today reported record fourth-quarter 2011 GAAP diluted EPS of $1.08, an increase of 22.7 percent, which includes expenses associated with the pending merger with Express Scripts, Inc. of $43.6 million before provision for income taxes. When excluding these merger-related expenses, diluted EPS increased 29.5 percent over fourth-quarter 2010.
› Verified 1 days ago
Geh Meh Chu, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-7062 | |
Dr. Michael A Amygdalos, Radiology Medicare: Accepting Medicare Assignments Practice Location: 640 S State Street, Dept Of Radiology, Dover, DE 19901 Phone: 302-674-2202 | |
Michael F Polise, D.O Radiology Medicare: Accepting Medicare Assignments Practice Location: 640 S State Street, Dept Of Radiology, Dover, DE 19901 Phone: 302-674-2202 | |
Rachel Taylor, Radiology Medicare: Not Enrolled in Medicare Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-7062 | |
James Mezger, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-480-1688 Fax: 302-480-9807 | |
Dr. Martin G Begley, Radiology Medicare: Not Enrolled in Medicare Practice Location: 640 S State Street, Dept Of Radiology, Dover, DE 19901 Phone: 302-674-2202 | |
Thomas E Vaughan, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-7062 Fax: 302-744-6215 |